DCF — ROSE MEDICAL CENTER
Enterprise Value: $221.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$221.3M
Enterprise Value
$56.3M
PV of Cash Flows
$164.9M
PV of Terminal Value
$265.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $357.6M | $30.4M | 8.0% | $9.9M | $9.0M |
| Year 2 | $368.3M | $35.0M | 9.0% | $13.0M | $10.7M |
| Year 3 | $379.4M | $39.8M | 10.0% | $16.2M | $12.2M |
| Year 4 | $390.7M | $43.0M | 11.0% | $18.1M | $12.4M |
| Year 5 | $402.5M | $45.3M | 11.0% | $19.4M | $12.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $221.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$347.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999976955864
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5